Resumen de DRUG DEVELOPMENT: A healthy pipeline.
Drugs for irritable bowel syndrome have so far been limited, but a promising stream of options could soon enter the market.
Drugs for irritable bowel syndrome have so far been limited, but a promising stream of options could soon enter the market.
